VistaGen Therapeutics
VTGN
#9309
Rank
A$0.11 B
Marketcap
$3.89
Share price
3.07%
Change (1 day)
-51.60%
Change (1 year)

EPS for VistaGen Therapeutics (VTGN)

EPS in 2023 (TTM): -$9.70

According to VistaGen Therapeutics 's latest financial reports the company's current EPS (TTM) is -$10.67. In 2022 the company made an earnings per share (EPS) of -$15.46 an increase over its 2021 EPS that were of -$16.06.

EPS history for VistaGen Therapeutics from 2008 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$9.70-37.24%
2022-$15.46-3.71%
2021-$16.0624.49%
2020-$12.90-55.17%
2019-$28.78-37.59%
2018-$46.12-32.16%
2017-$67.98-72.04%
2016-$243.14-84.16%
2015-$1,535298.71%
2014-$385.0583.45%
2013-$209.89-83.24%
2012-$1,25293.91%
2011-$645.69
2010N/A
2009N/A
2008N/A

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.61-66.20%๐Ÿ‡บ๐Ÿ‡ธ USA